Fast Money Stock Picks December 27 2007 – Hard Hits
Writedown fears, concern about the possibility of the economy slowing, and the assassination of Benazir Bhutto hit the Dow hard.

Adami:
UL – Unilver – Buy
PG – Proctor & Gamble – Buy
MO – Altria – Buy
USB – Bancorp – Buy
TSO – Tesoro – Buy
DELL – Dell – Buy
DIS – Disney – Could go down with slow economy, but good for long term
INTC – Intel – Buy for long term – “Final Trade”

Najarian:
FNM – Fannie Mae – Buy
FRE – Freddie Mac – Buy
TSO – Tesoro – Buy
ORCL – Oracle – Buy – Morgan Stanley’s “Top Pick”
AAPL – Apple – Buy – Deal with Fox to rent movies through iTunes, early pressure but should be higher in the long run
DELL – Dell – Buy
GS – Goldman Sachs – Buy – Don’t bottom pick
MS – Morgan Stanley – Buy – Don’t bottom pick
LEH – Lehman – Buy – Don’t bottom pick
DIS – Disney – Could go down with slow economy, but good for long term
ADM – Archer Daniels Midland – Buy – “Final Trade”

Macke:
TSO – Tesoro – Buy
DIS – Disney – Could go down with slow economy, but good for long term

Finerman:
Recommends selling your portfolio’s long-term losers (more than a year)
IYR – iShares Dow Jones US Real Estate ETF – Sell – “Final Trade”

Schaeffer:
XLF – Financial ETF – Sell
C- Citigroup – Sell

Huckman (Pharmaceuticals reporter):
MDT – Medtronic – Buy – FDA expected to approve new drug
ABT – Abbot – Buy – Also expected FDA approval of new product
DNA – Genentech – Has a new breast cancer drug but FDA approval is iffy
DNDN – Dendreon – New prostate cancer drug being tested.  Stock “not for the faint of wallet”

Gartman:
POT – Potash – Buy if dips.  “Keeps making new highs”

Writedowns
C – Citigroup
MER – Meryll Lynch
JPM – JP Morgan

Pops
FRE – Freddie Mac (4%).  Adami doesn’t like it.
WMG – Warner Music Group (2%). Macke: stay away.
CRUS – Citrus Logic (4%). Najarian: will probably drop tomorrow.

Drops
NOVN – Noven Pharmaceuticals (1%). Najarian: has a tentative agreement with the FDA, but that doesn’t necessarily translate into approval.
SPG – Simon Properties Group (3%). Finerman: stay short.
SLM – Sallie Mae (11%). Macke: selling stock, diluting value. Get out.
BA – Boeing (1%). Adami: cheap, but getting hammered.